Table 2.
Co-occurring disorders for all patients in the study of a therapy to reduce noncombat-related PTSD symptomsa
| Variable | No. (%) |
|---|---|
| Medical diagnoses | |
| Chronic pain | 12 (40) |
| Insomnia | 10 (33) |
| Obesity | 10 (33) |
| Asthma | 9 (30) |
| Obstructive sleep apnea | 8 (27) |
| Diabetes | 7 (23) |
| Migraine | 7 (23) |
| GERD | 6 (20) |
| Mental health diagnoses | |
| Depression | 21 (70) |
| Generalized anxiety disorder | 14 (47) |
| Panic disorder | 5 (17) |
a
This table includes information for all 30 patients in the study regarding diagnosed conditions with 5 or more participants. Although only 10 participants came into the PTSD treatment with an insomnia diagnosis, 21 (70%) of the patients in this study met the Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual, Fifth Edition clinical threshold for sleep disturbance.
GERD = gastroesophageal reflux disease; PTSD = posttraumatic stress disorder.